Compare Shell PLC (SHEL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs GeneDx Holdings Corp — how do they compare? Shell PLC trades at $100.18 (market cap $284.34B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Shell PLC is far larger — about 140.8× GeneDx Holdings Corp's market cap, and Shell PLC pays a 3.12% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Shell PLC for 90 Days and GeneDx Holdings Corp for 19 Days on average.
| SHEL | WGS | |
|---|---|---|
Market Cap | $284.34B | $2.02B |
Volume | 9,097,469 | 734,640 |
Sector | Energy | Health |
52-Week High | $100.20 | $167.51 |
52-Week Low | $70.31 | $34.51 |
Typical Hold Time | 90 Days | 19 Days |
Enterprise Value | $326.04B | $2.05B |
Dividend Yield | 3.12% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Shell (SHEL) trades at $100.2, up 3.46% today, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and recent earnings beats in Q1 and Q2 2026. Fundamentally, the company maintains solid profitability with an 8.76% net margin and attractive valuation multiples, including a P/E of 11.08. Recent news highlights strategic expansions in LNG capacity and carbon capture projects, reinforcing long-term growth prospects.
The outlook for SHEL is positive, supported by analyst consensus favoring Buy ratings and a $102.53 price target. Key opportunities include LNG expansion and portfolio optimization, while risks involve energy price volatility and execution of large-scale projects. The stock presents a balanced risk-reward profile for investors seeking exposure to energy transition themes.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
